Sunday, August 19, 2018 4:25:56 PM
I highly doubt AmeriMark and MediCann EU have a lifetime supply of OMHE product in warehouses that they purchased from OMHE out of the goodness of their heart with no intentions of ever reaching the retail market?
Obviously, it just ain't so, Joe. Notice the $3.7 million euro or $4.2 million USD didn't show up in OMHE's FY end filing.
A single mal-b-gone pharmacy.....in the ghetoooooo
In the ghettoooooooooo....
~Elvis
You mad, bro?
~Richard Sherman
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM